$BYND·8-K

BEYOND MEAT, INC. · Mar 6, 4:32 PM ET

Compare

BEYOND MEAT, INC. 8-K

Research Summary

AI-generated summary

Updated

Beyond Meat (BYND) Receives Nasdaq Deficiency Notice Over $1 Minimum Bid

What Happened
Beyond Meat, Inc. (BYND) filed an 8-K on March 6, 2026 reporting that Nasdaq’s Listing Qualifications Staff sent a deficiency letter on March 4, 2026 because the company’s closing bid price has been below the $1.00 minimum required for continued listing on the Nasdaq Global Select Market for 30 consecutive business days. The company’s shares will continue to trade on Nasdaq under the ticker BYND while it seeks to regain compliance.

Key Details

  • Nasdaq gave the company 180 calendar days to regain compliance — compliance date is August 31, 2026.
  • To cure the deficiency the closing bid must be at least $1.00 per share for a minimum of 10 consecutive business days before the compliance date.
  • If needed, the company may be eligible for an additional 180-day compliance period after transferring to The Nasdaq Capital Market and notifying Nasdaq of its intent to cure (which may require a reverse stock split).
  • On November 19, 2025, shareholders approved 30 alternative amendments to the certificate of incorporation allowing the Board to effect a reverse stock split (and corresponding authorized-share reduction) at a ratio chosen from those approved amendments.

Why It Matters
This notice signals a listing risk tied to Beyond Meat’s recent share price performance. If the company cannot get its closing bid back above $1.00 for the required period (or pursue and complete a board-authorized reverse stock split), it could face transfer to Nasdaq’s Capital Market or potential delisting proceedings — events that can affect liquidity, investor perception, and index inclusion. The company has the authority and options (including a reverse split) to try to regain compliance, but there is no assurance it will succeed.

Loading document...